Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HPV
Biotech
Antiva bags $53M series E to finance future HPV trials
Antiva is taking $53 million in new late-stage private funding to pay for a handful of upcoming trials testing its HPV treatment.
Max Bayer
Apr 27, 2023 7:27am
Merck KGaA hands over IL-12 cancer med for up to $121M
Jan 3, 2023 2:17pm
J&J culls Bavarian Nordic pacts for HPV, hep B vax
May 9, 2022 9:47am
Inovio falls victim to AstraZeneca's 'usual pipeline pruning'
Nov 1, 2021 10:22am
With FDA nod, BD brings automated diagnostics system to U.S.
Aug 25, 2021 11:55am
ISA Pharma snags $30M from Regeneron, others for HPV16 hopeful
Jul 13, 2021 11:30am